Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Thermo Fisher ScientificBSP:TMOS34 +0.74%74 Cash Ratio is 0.22 as of Mar. 2026, which is 35% below its 10-year median of 0.34. GuruFocus rates BSP:TMOS34 with a GF Score™ of 74/100 and a GF Value™ of R$61.73 (Fairly Valued). The stock has 5 warning signs investors should review. Among 208 Medical Diagnostics & Research companies, Thermo Fisher Scientific ranks worse than 81.25% on this metric.
Thermo Fisher Scientific has a Cash Ratio of 0.22. It indicates that there are more current liabilities than Cash, Cash Equivalents, Marketable Securities, and the company does not have sufficient cash on hand to pay off its short-term debt.
The historical rank and industry rank for Thermo Fisher Scientific's Cash Ratio or its related term are showing as below:
BSP:TMOS34'
s Cash Ratio Range Over the Past 10 Years
Min: 0.11 Med: 0.34 Max: 1.55
Current: 0.22
During the past 13 years, Thermo Fisher Scientific's highest Cash Ratio was 1.55. The lowest was 0.11. And the median was 0.34.
BSP:TMOS34's Cash Ratio is ranked worse than 81.25% of 208
companies
in the Medical Diagnostics & Research industry
Industry Median: 0.965
vs BSP:TMOS34: 0.22
Thermo Fisher Scientific (BSP:TMOS34) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Thermo Fisher Scientific Cash Ratio Related Terms
Thermo Fisher Scientific Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Diagnostics & Research subindustry, Thermo Fisher Scientific's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Thermo Fisher Scientific Cash Ratio vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Thermo Fisher Scientific's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Thermo Fisher Scientific's Cash Ratio falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thermo Fisher Scientific (BSP:TMOS34) has a Cash Ratio of 0.22 as of Mar. 2026. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Thermo Fisher Scientific and its competitors. This is 35% below median its historical median of 0.34. Over the past decade, Thermo Fisher Scientific's Cash Ratio has ranged from 0.11 to 1.55. According to the industry distribution chart, Thermo Fisher Scientific ranks #169 out of 208 companies in the Medical Diagnostics & Research industry, placing it in the top 81.2%.
Is Thermo Fisher Scientific's Cash Ratio too high?
Thermo Fisher Scientific's current Cash Ratio of 0.22 is 35% below median its 10-year median of 0.34. Over the past 10 years, this metric has ranged from a low of 0.11 to a high of 1.55. The Medical Diagnostics & Research industry median Cash Ratio is 0.97. Thermo Fisher Scientific's value of 0.22 is 77.2% below this industry median. Based on the distribution chart, Thermo Fisher Scientific ranks #169 out of 208 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Thermo Fisher Scientific has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Thermo Fisher Scientific's Cash Ratio compare to DHR and IDXX?
According to the Medical Diagnostics & Research industry distribution chart, Thermo Fisher Scientific ranks #169 out of 208 companies for Cash Ratio. This places Thermo Fisher Scientific in the lower half of its industry. The industry median Cash Ratio is 0.97. Thermo Fisher Scientific's value of 0.22 is 77.2% below this benchmark. Historically, Thermo Fisher Scientific's own Cash Ratio has ranged from 0.11 to 1.55 over the past decade. While the company's 10-year median is 0.34 vs. the industry median of 0.97, Thermo Fisher Scientific has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Ratio for a Medical Diagnostics & Research company?
The median Cash Ratio among Medical Diagnostics & Research companies is 0.97, based on 208 companies in the industry. Companies in the top quartile (top 25%) have a Cash Ratio significantly above this median, while those in the bottom quartile fall well below. However, Cash Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Thermo Fisher Scientific's current Cash Ratio of 0.22 is 77.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Ratio mean?
A high Cash Ratio can signal that a stock is expensive relative to its fundamentals. Cashflow ratio is the ratio of Cash, Cash Equivalents, Marketable Securities to current liabilities. View historical data on Thermo Fisher Scientific and its competitors. For the Medical Diagnostics & Research industry, the median Cash Ratio is 0.97 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Thermo Fisher Scientific's current Cash Ratio is 0.22, which is 35% below median its own 10-year median of 0.34. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Thermo Fisher Scientific stock overvalued right now?
Based on GuruFocus' analysis, Thermo Fisher Scientific (BSP:TMOS34) is currently considered Fairly Valued. The stock's GF Value™ is R$61.73, compared to a current price of R$57.21 — trading 7.3% below its estimated fair value. The current Cash Ratio is 0.22, which is 35% below median its 10-year median of 0.34 and 77.2% below the Medical Diagnostics & Research industry median of 0.97. Thermo Fisher Scientific's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Ratio calculated?
Cash Ratio is calculated from a company's financial statements. For Thermo Fisher Scientific (BSP:TMOS34), the current Cash Ratio is 0.22 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Thermo Fisher Scientific (BSP:TMOS34) Overvalued in 2026?
Based on GuruFocus' analysis, Thermo Fisher Scientific stock appears to be undervalued.
The current stock price of R$57.21 is trading 7.3% below its estimated GF Value™ of R$61.73.
GuruFocus considers Thermo Fisher Scientific to be Fairly Valued.
Key valuation signals for BSP:TMOS34:
Cash Ratio: 0.22 (35% below median its 10-year median of 0.34)
GF Value™: R$61.73 vs. price of R$57.21 (7.3% below fair value)
Industry Position: 77.2% below the Medical Diagnostics & Research median (#169 of 208)
No single metric tells the full story. See the BSP:TMOS34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2025 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).
74GF Score
Get the complete analysis for BSP:TMOS34
Cash Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:TMOS34 has been successfully added to your 
